These findings represent a novel mechanism underlying arrhythmogenesis in TMEM43‐related ARVC and point to RYR2 stabilization as a potential therapeutic strategy. This evidence concerns the gene TMEM43 and Arrhythmogenic right ventricular dysplasia.